Hikma Pharmaceuticals · 5 days ago
Analyst, Portfolio & Offer Development
Berkeley Heights, NJ
Full-time
Onsite
New Grad, Entry Level
$56K/yr - $95K/yr
0+ years expHikma Pharmaceuticals is a developer, manufacturer, and supplier of essential medicines, committed to bringing better health within reach every day. They are seeking a talented and motivated Analyst, Portfolio & Offer Development to manage forecasting, pricing, and portfolio management while collaborating with national account sales directors.
Health CareMedicalPharmaceutical
Responsibilities
Develop pricing proposals for Generics business products in response to customer inquiries
Maintain customer pricing proposal databases and models
Assist with the preparation price increase analyses as required and WAC reviews quarterly
Perform ad-hoc analysis as necessary
Assist in life cycle management and portfolio optimization processes
Monitor competitive developments and establish new sources of competitive intelligence
Performing forecasting / quantitative analyses (including pro-forma financial modelling, valuation, accretion/dilution, IRR/NPV, etc.) on new lifecycle management opportunities
Further develop customer level forecast and monthly reporting
Create and maintain monthly sales reporting – partnering with sales team on variance & supporting commentary analysis
Assist with the preparation of customer business reviews (forecasting / allocation / backorder analytics)
Gather and maintain up to date information on sales and market share, and information with promotional potential
Participate on cross functional, multidisciplinary teams and contribute to reaching product objectives
Qualification
Required
Bachelor's degree in Finance, Accounting, Marketing, Business, or Engineering required
0-2 years of relevant experience; pharmaceutical industry experience is preferred
Quick learner with strong critical thinking and problem solving skills (both conceptually and technically)
Strong communication, excellent organization and coordination skills and impeccable attention to detail with the ability to effectively handle multiple complex issues simultaneously
Experience in Excel including pivot tables and integrating and consolidating large volumes of data from various sources
Ability to work both independently and as a flexible team player while working in a dynamic, fast-paced and entrepreneurial environment
Preferred
Pharmaceutical industry experience
Benefits
Annual performance bonus, commission, and share potential
Auto enrollment in a Hikma-sponsored 401(k) program at a pre-tax contribution rate of 3% of eligible pay. Hikma will match 100% of the first 6% of eligible pay that you contribute
A generous paid time off (PTO) bank starting with 20 days (prorated based on hire date). Additional days granted upon reaching work milestone anniversaries.
3 personal days (prorated based on hire date)
11 company paid holidays
Comprehensive benefits including health, dental, vision, mental health, disability, life insurance, prescription drug coverage, and a variety of voluntary benefits
Employee discount program
Wellbeing rewards programs
Safety and Quality is a top organizational priority
Career advancement and growth opportunities
Tuition reimbursement
Paid maternity and parental leave
Eligibility requirements apply to some benefits and depend on the job classification, role, and length of employment. Benefits are subject to change as well as specific plan or program terms.
Company
Hikma Pharmaceuticals
Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products
5001-10000 employees
H1B Sponsorship
Hikma Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (16)
2024 (23)
2023 (22)
2022 (24)
2021 (28)
2020 (18)
Funding
Current Stage
Public CompanyTotal Funding
$250MKey Investors
International Finance Corporation
2025-07-15Post Ipo Debt· $250M
2005-11-04IPO
Leadership Team
Said Darwazah
Chief Executive Officer
Khalid Nabilsi
Chief Financial Officer
Recent News
2026-01-09
London Evening Standard
2025-12-16
2025-12-15
Company data provided by crunchbase